TMCI Treace Medical Concepts, Inc.
Healthcare$2.83+0.00%OpenMarket Cap: $183.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.33
P/S
0.87
EV/EBITDA
-3.91
DCF Value
$-7.29
FCF Yield
-14.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.7%
Operating Margin
-26.9%
Net Margin
-29.4%
ROE
-69.5%
ROA
-33.2%
ROIC
-37.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $47.2M | 79.3% | $-17.2M | $-18.0M | $— | — |
| Q4 null | $62.5M | 80.6% | $-5.9M | $-9.4M | $— | — |
| FY null | $212.7M | 79.8% | $-54.2M | $-59.0M | $— | — |
| Q3 null | $50.2M | 79.1% | $-15.7M | $-16.3M | $— | — |
| Q2 null | $47.4M | 79.7% | $-17.0M | $-17.4M | $— | — |
| Q1 null | $52.6M | 79.7% | $-15.6M | $-15.9M | $— | — |
| Q4 null | $68.7M | 80.7% | $-204.0K | $-501.0K | $— | — |
| FY null | $209.4M | 80.4% | $-55.7M | $-55.7M | $— | — |
| Q3 null | $45.1M | 80.1% | $-15.1M | $-15.4M | $— | — |
| Q2 null | $44.5M | 80.2% | $-21.4M | $-21.2M | $— | — |
| Q1 null | $51.1M | 80.2% | $-19.0M | $-18.7M | $— | — |
| Q4 2023 | $62.2M | 81.6% | $-6.8M | $-6.3M | $-0.10 | — |